Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Fair Value (Tables)

Fair Value (Tables)

3 Months Ended

Mar. 31, 2016

Schedule of financial assets measured at fair value on a recurring basis

Financial assets measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations (in thousands):


	Assets at Fair Value as of March 31, 2016
	Level 1		Level 2		Level 3		Total
Money market funds	$	4,883	$	—	$	—	$	4,883
U. S. treasury bills		—		9,062		—		9,062
Government-sponsored enterprise securities		—		29,236		—		29,236
Corporate bonds and commercial paper		—		60,113		—		60,113
Total	$	4,883	$	98,411	$	—	$	103,294


	Assets at Fair Value as of December 31, 2015
	Level 1		Level 2		Level 3		Total
Money market funds	$	26,291	$	—	$	—	$	26,291
U. S. treasury bills		—		9,048		—		9,048
Government-sponsored enterprise securities		—		48,613		—		48,613
Corporate bonds and commercial paper		—		40,206		—		40,206
Total	$	26,291	$	97,867	$	—	$	124,158